⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ros1 gene rearrangements

Every month we try and update this database with for ros1 gene rearrangements cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)NCT02568267
Breast Cancer
Cholangiocarcin...
Colorectal Canc...
Head and Neck N...
Lymphoma, Large...
Melanoma
Neuroendocrine ...
Non-Small Cell ...
Ovarian Cancer
Pancreatic Canc...
Papillary Thyro...
Primary Brain T...
Renal Cell Carc...
Sarcomas
Salivary Gland ...
Adult Solid Tum...
Entrectinib
18 Years - Hoffmann-La Roche
Study of Oral JYP0322 in Patients With Locally Advanced or Metastatic Cancer Targeting ROS1 Molecular Fusion.NCT06128148
Protein Kinase ...
Other Protocol ...
Lung Neoplasms
Brain Neoplasms
JYP0322
18 Years - Guangzhou JOYO Pharma Co., Ltd
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: